Bluezone Insurance is a company.
Bluezone Insurance has raised $2.0M across 1 funding round.
Key people at Bluezone Insurance.
Bluezone Insurance has raised $2.0M in total across 1 funding round.
Key people at Bluezone Insurance.
Blueberry Life (formerly Bluezone Insurance) is a UK-based insurtech startup specializing in term life insurance for individuals with chronic conditions, particularly type 1 and type 2 diabetes, as well as high BMI, hypertension, high cholesterol, and pre-diabetes. It serves people often denied coverage by traditional insurers, offering personalized policies up to £350,000 with terms of 5-30 years, entry ages 19-71, and no medical tests required—just a 5-minute online application for same-day cover.[1][2][4][7] The company solves the problem of inaccessible, unfair underwriting for high-risk groups by using AI/ML-driven risk engines for precise, dynamic pricing that rewards health improvements, integrated with lifestyle apps like Gro Health for behavior change support, potentially lowering premiums over time.[1][2][4]
Growth momentum includes a 2020 launch with initial funding, a 2023 pivot to diabetes-focused insurance, partnerships with Shepherds Friendly and Gro Health, and a recent rebrand to Blueberry Life to expand product scope, reflecting strong traction in addressing a market gap where over 5 million UK diabetes patients face coverage barriers.[1][3][4][7]
Founded by Dr. Karan Mehta, a former NHS doctor with three and a half years of clinical experience, Blueberry Life emerged from his frustration with reactive healthcare and desire for scalable, proactive impact. During medical school and early career, Mehta pursued ideas stifled by the system, leading him to insurtech where incentives align with health promotion; a conversation with a relative about lifestyle-driven health alternatives sparked the pivot.[1][3][4]
In early 2020, Mehta raised his first investment round, found a co-founder, and officially launched amid challenges like the pandemic, which tested resilience but honed adaptability. By 2023, informed by PhD research on AI/ML underwriting and chronic disease datasets, he course-corrected to launch Bluezone as the first specialist term life insurer for type 2 diabetes patients, evolving into Blueberry Life by 2024 with broader chronic condition coverage.[1][2][4][7]
Blueberry Life rides the insurtech wave merging AI, precision medicine, and behavioral economics to democratize insurance for the "uninsurable," amid rising chronic disease prevalence (e.g., 6-8% of UK population with diabetes) and demand for personalized financial protection.[1][3][5] Timing aligns with post-pandemic health awareness, regulatory pushes for inclusivity, and AI advancements enabling automated underwriting at scale, countering traditional insurers' outdated manual processes.[2][4]
Market forces like aging populations, escalating healthcare costs, and wellness tech boom favor its model, influencing the ecosystem by proving viable "healthspan" insurance—improving insurer profitability via lower loss ratios while boosting societal productivity through healthier lives.[3][7]
Blueberry Life is poised to scale beyond diabetes into more chronic conditions, leveraging partnerships and its data-led engine for broader "precision healthcare through insurance." Trends like AI personalization, wearable health integration, and dynamic pricing will propel growth, potentially expanding geographically as global chronic disease rates climb.[1][4][7] Its influence may evolve from niche disruptor to ecosystem shaper, redefining insurtech incentives to prioritize prevention—ultimately making coverage as individualized as the conditions it serves, tying back to its mission of fairer, healthier lives for millions underserved by legacy systems.[2][3]
Bluezone Insurance has raised $2.0M in total across 1 funding round.
Bluezone Insurance's investors include AV8 Ventures, Citi Ventures, Outrun Ventures, Passion Capital, SCOR Ventures, Ten Eleven Ventures, Tribe Capital, Will Brooks.
Bluezone Insurance has raised $2.0M across 1 funding round. Most recently, it raised $2.0M Seed in May 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 1, 2022 | $2.0M Seed | AV8 Ventures, Citi Ventures, Outrun Ventures, Passion Capital, SCOR Ventures, Ten Eleven Ventures, Tribe Capital, Will Brooks |
